Gabriel Siqueira dos Santos , André Luiz Mota da Costa , Mariana Castilho Martins , Rodrigo Hidalgo Friciello Teixeira , Luciana Sartori , Natália Carrillo Gaeta , Gisele Oliveira de Souza , José Soares Ferreira Neto , Marcos Bryan Heinemann
{"title":"New Delhi Metallo-beta-lactamase-5-producing Escherichia coli ST48 isolated from Giant Anteater (Myrmecophaga tridactyla)","authors":"Gabriel Siqueira dos Santos , André Luiz Mota da Costa , Mariana Castilho Martins , Rodrigo Hidalgo Friciello Teixeira , Luciana Sartori , Natália Carrillo Gaeta , Gisele Oliveira de Souza , José Soares Ferreira Neto , Marcos Bryan Heinemann","doi":"10.1016/j.vetmic.2025.110580","DOIUrl":null,"url":null,"abstract":"<div><div>Carbapenemase-producing <em>Escherichia coli</em> are frequently related to healthcare-associated infections. Still, those have been reported from variable sources, including wild and zoo animals, posing a substantial threat to the conservation of animal species vulnerable to extinction. In this study, we reported an NDM-5-producing <em>E. coli</em> ST 48 isolated from rectal swab collected on April 21st, 2024 from a healthy Giant Anteater (<em>Myrmecophaga tridactyla</em>) in a Brazilian Zoo. The <em>E. coli</em> strain showed antimicrobial-resistant genes to quinolones, tetracyclines, and beta-lactams, including carbapenems, cephalosporins, and penicillins, besides a wide range of virulence factors encoding genes. Phylogenomic analysis showed that the NDM-5-producing <em>E. coli</em> ST48 strain clustered with lineages from Myanmar and China. Its <em>bla</em><sub>NDM-5</sub> genetic context shared insertion sequences and adjacent genes with other ST48 strains. This is the first report of NDM-5-producing <em>E. coli</em> isolated from a zoo animal in Brazil, highlighting the potential to species conservation and the importance of monitoring antimicrobial-resistant bacteria in zoo animals.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"307 ","pages":"Article 110580"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525002159","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Carbapenemase-producing Escherichia coli are frequently related to healthcare-associated infections. Still, those have been reported from variable sources, including wild and zoo animals, posing a substantial threat to the conservation of animal species vulnerable to extinction. In this study, we reported an NDM-5-producing E. coli ST 48 isolated from rectal swab collected on April 21st, 2024 from a healthy Giant Anteater (Myrmecophaga tridactyla) in a Brazilian Zoo. The E. coli strain showed antimicrobial-resistant genes to quinolones, tetracyclines, and beta-lactams, including carbapenems, cephalosporins, and penicillins, besides a wide range of virulence factors encoding genes. Phylogenomic analysis showed that the NDM-5-producing E. coli ST48 strain clustered with lineages from Myanmar and China. Its blaNDM-5 genetic context shared insertion sequences and adjacent genes with other ST48 strains. This is the first report of NDM-5-producing E. coli isolated from a zoo animal in Brazil, highlighting the potential to species conservation and the importance of monitoring antimicrobial-resistant bacteria in zoo animals.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.